GlassScriptPhysician profile
Julia B Goodwin
NPI 1184852378
$16,337.56
in general payments reported to CMS, 2019-2025
36 companies · $2,188 in 2025
The $2,188 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,998 · 2020: $3,521 · 2021: $930 · 2022: $1,637 · 2023: $3,087 · 2024: $1,976 · 2025: $2,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,973 · Travel and Lodging: $1,972 · Consulting Fee: $175 · Education: $85.95 · Gift: $44.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,973.20 |
| Travel and Lodging | $1,972.43 |
| Consulting Fee | $175.00 |
| Education | $85.95 |
| Gift | $44.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,044.26 | 2019-2025 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $3,676.44 | 2020-2023 | |
| Abbvie INC. | $1,954.05 | 2019-2023 | |
| Astellas Pharma US INC | $382.45 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $319.51 | 2023-2025 | Myfembree |
| Pfizer INC. | $220.02 | 2019-2023 | |
| Hologic Sales and Service, LLC | $193.30 | 2019-2023 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $164.96 | 2019-2025 | |
| Exeltis, USA INC. | $158.36 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $156.24 | 2021-2025 | |
| Myovant Sciences INC. | $121.59 | 2021-2022 | |
| Avion Pharmaceuticals | $120.27 | 2020-2022 | |
| Organon LLC | $114.70 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $79.71 | 2021-2022 | |
| Therapeuticsmd, INC. | $68.58 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $68.24 | 2023-2025 | Evenity, Prolia |
| Lilly USA, LLC | $50.12 | 2020 | |
| Coopersurgical, INC. | $46.19 | 2023-2024 | Advincula Delineator Uterine Manipulator, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Sage Therapeutics, LLC | $39.62 | 2020 | |
| Ethicon US, LLC | $32.47 | 2020 | |
| Minerva Surgical, INC | $32.28 | 2021-2023 | |
| Becton, Dickinson and Company | $31.91 | 2022 | |
| Merck Sharp & Dohme LLC | $28.79 | 2019-2024 | Gardasil, Gardasil 9 |
| Duchesnay USA Incorporated | $24.56 | 2019 | |
| Integra Lifesciences Corporation | $24.13 | 2025 | Tenoglide |
| Mycovia Pharmaceuticals, INC. | $22.47 | 2023 | Vivjoa |
| Scynexis, INC. | $20.34 | 2022 | |
| Biogen, INC. | $19.94 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $16.94 | 2022 | |
| Molnlycke Health Care US, LLC | $15.88 | 2021 | |
| Mylan Pharmaceuticals INC. | $15.34 | 2022 | |
| Millicent US INC | $15.27 | 2024 | Femring, Intrarosa |
| Vertex Pharmaceuticals Incorporated | $15.11 | 2025 | |
| Allergan, INC. | $15.05 | 2020 | |
| Amag Pharmaceuticals, INC. | $14.26 | 2019 | |
| Kci USA, INC. | $14.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.